Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Multi-Center, Phase III Study of Allogeneic Stem Cell Transplantation Comparing Regimen Intensity in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia (BMT CTN #0901)

NCT01339910 is registered in ClinicalTrials.gov with Medical College of Wisconsin as lead sponsor.

NCT NCT01339910
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01339910 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Multi-Center, Phase III Study of Allogeneic Stem Cell Transplantation Comparing Regimen Intensity in Patients With Myelodysplastic Syndrome or Acute Myeloid Leukemia (BMT CTN #0901)
Lead sponsor
Medical College of Wisconsin
Phase
Phase 3
Overall status
Terminated
Start date
June 30, 2011
Completion date
October 16, 2017
Enrollment
272 (actual)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, myelocytic, acute